January 2018 - Renew Biopharma

Changing the Course Of Pain Management. Opioid Crisis Has Cos. Looking to Develop Safer Treatments

olga2018-10-01T16:56:14-07:00January 29th, 2018|Latest Articles|

San Diego — In 2014, Heron Therapeutics took notice of the role of postoperative pain in opioid addiction. So, the company dusted off a shelved drug program. Heron is among the San Diego pharma and biotechs rushing to market with alternatives to opioids, dependence on which mushroomed into a national health epidemic. Their treatments aim to prevent dependence, overdoses and side effects.

Renew Biopharma Launches Pre-Clinical Drug Discovery Program with Indiana University Bloomington’s Gill Center for Biomolecular Science Using Cannabinoids Grown in Microalgae

olga2018-02-16T19:24:03-08:00January 8th, 2018|Latest Articles|

SAN DIEGO -- In a collaboration that could lead to a new class of drugs to replace opioids and help fight the national opioid epidemic, Renew Biopharma today announced it is collaborating with Ken Mackie from the Indiana University (Bloomington) Gill Center for Biomolecular Science to help screen and develop human therapeutics using Renew’s natural and novel cannabinoid molecules in a pre-clinical drug discovery program.